ALKEM.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally...

Stats
今日成交量	471 348
平均成交量	242 921
市值	615.63B
EPS	INR49.76 ( 2024-02-09 )
下一个收益日期	( INR0 ) 2024-05-16
Last Dividend	INR10.00 ( 2023-08-09 )
Next Dividend	INR0 ( N/A )
P/E	39.18
ATR14	INR7.38 (0.14%)

音量相关性

長: 0.33 (neutral)

短: 0.23 (neutral)

Signal:(49.818) Neutral

Alkem Laboratories 相关性

10 最正相关
MASPTOP50.NS	0.902
MAFANG.NS	0.885
BAJAJ-AUTO.NS	0.881
HARIOMPIPE.NS	0.876
MON100.NS	0.869
SETF10GILT.NS	0.868
DATAPATTNS.NS	0.868
MANINDS.NS	0.865
MOGSEC.NS	0.862
GTNTEX.NS	0.861

10 最负相关
MOHOTAIND.NS	-0.877
ROLTA.NS	-0.865
SECURKLOUD.NS	-0.864
SUMICHEM.NS	-0.861
RUSHIL.NS	-0.852
CLNINDIA.NS	-0.849
BAFNAPH.NS	-0.848
LICI.NS	-0.847
DPSCLTD.NS	-0.846
EASTSILK.NS	-0.841

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Alkem Laboratories 相关性 - 货币/商品

0.78
( moderate )

0.75
( moderate )

0.79
( moderate )

0.58
( weak )

0.54
( weak )

0.17
( neutral )

Alkem Laboratories 财务报表

Annual	2022
营收:	INR115.99B
毛利润:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
营收:	INR115.99B
毛利润:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
营收:	INR105.12B
毛利润:	INR62.29B (59.25 %)
EPS:	INR137.63

FY	2021
营收:	INR87.47B
毛利润:	INR51.61B (59.00 %)
EPS:	INR132.57

Financial Reports:

No articles found.

Alkem Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR4.00 (N/A)	INR0 (N/A)	INR25.00 (N/A)	INR0 (N/A)	INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alkem Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.90 - low (29.79%) | Divividend Growth Potential Score: 5.50 - Stable (9.99%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR9.70	2016-03-18
Last Dividend	INR10.00	2023-08-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	INR177.70	--
Avg. Dividend % Per Year	0.71%	--
Score	2.85	--
Div. Sustainability Score	3.90
Div.Growth Potential Score	5.50
Div. Directional Score	4.70	--

Next Divdend (Est)
(2024-08-08)

INR8.69 Estimate 7.41 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.85

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR13.00	0.65%
2019	INR16.00	0.83%
2020	INR25.00	1.20%
2021	INR30.00	1.02%
2022	INR34.00	0.93%
2023	INR35.00	1.17%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TCPLPACK.NS	Dividend Junior	2023-07-27	Annually	7	1.08%
OFSS.NS	Dividend Knight	2023-05-09	Annually	23	4.19%
INGERRAND.NS	Dividend Junior	2023-07-17	Annually	23	1.40%
CONTROLPR.NS	Dividend Junior	2023-07-14	Semi-Annually	9	1.80%
SESHAPAPER.NS	Dividend Knight	2023-06-07	Annually	23	1.14%
MANAKCOAT.NS	Dividend Junior	2023-08-22	Sporadic	4	0.09%
GOODYEAR.NS	Dividend Knight	2023-07-26	Annually	5	4.02%
AVANTIFEED.NS	Dividend Junior	2023-08-03	Annually	14	0.86%
TRIL.NS	Dividend Junior	2023-07-27	Sporadic	17	0.22%
PILANIINVS.NS	Dividend Junior	2023-08-29	Annually	13	0.56%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.125	1.500	7.51	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.163	1.500	9.30	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	18.58	1.000	4.23	4.23	[3 - 30]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.597	1.000	3.38	3.38	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.63	8.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.35	1.000	6.33	0	[1 - 100]
returnOnEquityTTM	0.163	2.50	9.55	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.916	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	9.78	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0466	1.000	-1.336	0	[0.1 - 0.5]
Total Score				5.50

Alkem Laboratories

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.